Artículos por temáticas

Microglial activation states and their implications for Alzheimer's Disease

Valiukas Z, Tangalakis K, Apostolopoulos V, Feehan J.

J Prev Alzheimers Dis. 2025 Jan;12(1):100013. doi: 10.1016/j.tjpad.2024.100013. Epub 2025 Jan 1.

Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis

Arroyo-Pacheco N, Sarmiento-Blanco S, Vergara-Cadavid G, Castro-Leones M, Contreras-Puentes N.

Ageing Res Rev. 2025 Feb;104:102620. doi: 10.1016/j.arr.2024.102620. Epub 2024 Dec 3.

Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics

Dhapola R, Kumari S, Sharma P, Vellingiri B, HariKrishnaReddy D.

Brain Res. 2025 Mar 15;1851:149494. doi: 10.1016/j.brainres.2025.149494. Epub 2025 Feb 6.

Promising Natural Remedies for Alzheimer's Disease Therapy

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2025 Feb 17;30(4):922. doi: 10.3390/molecules30040922.

Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes

Sun M, Wang X, Lu Z, Yang Y, Lv S, Miao M, Chen WM, Wu SY, Zhang J.

Diabetes Metab. 2025 Mar;51(2):101623. doi: 10.1016/j.diabet.2025.101623. Epub 2025 Feb 12.

Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease

Kumari S, Bagri K, Deshmukh R.

Inflammopharmacology. 2025 Feb;33(2):593-603. doi: 10.1007/s10787-024-01638-1. Epub 2025 Jan 14.

Application of carbon-based nanomaterials in Alzheimer's disease

Bai M, Shao X, Wang C, Wang J, Wang X, Guan P, Hu X.

Mater Horiz. 2025 Feb 3;12(3):673-693. doi: 10.1039/d4mh01256a.

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease

Azam U, Naseer MM, Rochais C.

Eur J Med Chem. 2025 Mar 15;286:117277. doi: 10.1016/j.ejmech.2025.117277. Epub 2025 Jan 17.

Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds

Naik RA, Rajpoot R, Koiri RK, Bhardwaj R, Aldairi AF, Johargy AK, Faidah H, Babalghith AO, Hjazi A, Alsanie WF, Alamri AS, Alhomrani M, Alsharif A, Shkodina A, Singh SK.

J Prev Alzheimers Dis. 2025 Jan;12(1):100004. doi: 10.1016/j.tjpad.2024.100004. Epub 2025 Jan 1.

The Beneficial Effects of Combined Exercise and Polyphenols in Alzheimer's Disease

Tan Q.

Phytother Res. 2025 Feb;39(2):1020-1034. doi: 10.1002/ptr.8422. Epub 2024 Dec 24.

Role of 11β-Hydroxysteroid Dehydrogenase and Mineralocorticoid Receptor on Alzheimer's Disease Onset: A Systematic Review

Di Vincenzo M, Pellegrino P, Schiappa G, Campanati A, Del Vescovo V, Piccirillo S, Ambrogini P, Arnaldi G, Orciani M.

Int J Mol Sci. 2025 Feb 6;26(3):1357. doi: 10.3390/ijms26031357.

The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease

Maki Y, Ubuka T, Yamane Y.

J Alzheimers Dis. 2025 Jan;103(2):358-360. doi: 10.1177/13872877241301806. Epub 2024 Dec 5.

Potential implications of polyphenolic compounds in neurodegenerative diseases

Shi R, Gao D, Stoika R, Liu K, Sik A, Jin M.

Crit Rev Food Sci Nutr. 2024;64(16):5491-5514. doi: 10.1080/10408398.2022.2155106. Epub 2022 Dec 16.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Oligodendrocytes Play a Critical Role in White Matter Damage of Vascular Dementia

Zhang H, Yang Y, Zhang J, Huang L, Niu Y, Chen H, Liu Q, Wang R.

Neuroscience. 2024 Feb 6;538:1-10. doi: 10.1016/j.neuroscience.2023.10.018. Epub 2023 Oct 31.